PPARγ influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis

Keyphrases

• 7,12-dimethylbenz(a)anthracene 100%
• Peroxisome Proliferator-activated Receptor 100%
• Mammary Carcinogenesis 100%
• Skin Carcinogenesis 100%
• Fold Increase 50%
• Tumor 16%
• Increased Vulnerability 16%
• Oncogenesis 16%
• Skin Papilloma 16%
• Inflammation 8%
• Survival Rate 8%
• Wild Mice 8%
• Breast Cancer 8%
• Colon Cancer 8%
• Type 2 Diabetes Mellitus (T2DM) 8%
• Ligand-receptor Binding 8%
• Chemoprevention 8%
• Malignant Tumor 8%
• Increased Incidence 8%
• Congenic 8%
• Ovarian Cancer 8%
• Adipocyte Differentiation 8%
• Macrophage Response 8%
• Skin Cancer 8%
• Mammary Tumor 8%
• Specific Ligands 8%
• Nuclear Receptor Superfamily 8%
• Carcinogen-induced 8%
• Ovarian Granulosa Cells 8%
• Gavage 8%
• Beneficial Role 8%
• Littermate Controls 8%
• Haploinsufficiency 8%
• Mammary Adenocarcinoma 8%
• Cell Carcinoma 8%
• Heterozygous Mice 8%

Medicine and Dentistry

• Peroxisome Proliferator Activated Receptor 100%
• 7,12 Dimethylbenz[a]anthracene 100%
• Skin Carcinogenesis 100%
• Neoplasm 25%
• Carcinogenesis 25%
• Skin Papilloma 16%
• Carcinogen 8%
• Malignant Neoplasm 8%
• In Vitro 8%
• Breast Cancer 8%
• Survival Rate 8%
• Maturity Onset Diabetes of the Young 8%
• Ovarian Cancer 8%
• Macrophage Response 8%
• Chemoprophylaxis 8%
• Cell Nucleus Receptor 8%
• Skin Cancer 8%
• Haploinsufficiency 8%
• Colon Carcinoma 8%
• Feeding 8%
• Breast Adenocarcinoma 8%
• Adipocyte 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Peroxisome Proliferator Activated Receptor 100%
• Skin Carcinogenesis 100%
• 7,12-Dimethylbenz(a)anthracene 100%
• Neoplasm 25%
• Carcinogenesis 25%
• Skin Papilloma 16%
• Carcinogen 8%
• Malignant Neoplasm 8%
• Breast Cancer 8%
• Survival Rate 8%
• Inflammation 8%
• Ovary Cancer 8%
• Skin Cancer 8%
• Cell Nucleus Receptor 8%
• Breast Adenocarcinoma 8%
• Colon Carcinoma 8%